| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 1992 Oxford University Press
other |
Familial Aggregation of Oesophageal Cancer in Yangcheng County, Shanxi Province, China
,
* Department of Cell Biology. Cancer Institute, Chinese Academy of Medical Sciences Beijing, China
Cancer Prevention Studies Branch, Division of Cancer Prevention and Control, National Cancer Institute Bethesda. MD, USA
Fox Chase Cancer Center Philadelphia, PA, USA
§ Yangcheng County Cancer Institute Shanxi, China
| Shanxi Tumor Hospital Taiyuan, Shanxi, China
Reprint requests: Dr P R Taylor, NCI, NIH, EPN, Room 211, Bethesda, MD 20892, USA
Hu N (Department of Cell Biology, Cancer Institute, Chinese Academy of Medical Sciences, Beijing, China), Dawsey S M, Wu M, Bonney G E, He L J, Han X Y, Fu M and Taylor P R. Familial aggregation of oesophageal cancer in Xangcheng County. International Journal of Epidemiology 1992; 21: 877–882
Oesophageal cancer is the second most common cause of cancer death in China and is particularly prevalent in northern China. Genetic factors have been studied less than environmental factors in the aetiology of this disease. This study was conducted to evaluate familial aggregation of oesophageal cancer. All households in Yangcheng County were interviewed in 1979 to determine family history of oesophageal cancer. In 1989, vital status for all family members from three Yangcheng villages was determined and re-interviews were conducted among families who reported a positive family history of oesophageal cancer in 1979. Risk of oesophageal cancer was evaluated by comparing family and individual rates of oesophageal cancer during the 1979–1989 interval stratified by the number of family members with oesophageal cancer prior to 1979. More families with prior oesophageal cancer history reported new oesophageal cancer deaths during the follow-up period than families without prior history (19% versus 5%). Oesophageal cancer rates increased with increasing positivity of family history, and adjustment for other risk factors did not substantially alter this result. We conclude that these data provide evidence for familial aggregation of oesophageal cancer.
Received 1 April 1992
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  W. Garavello, E. Negri, R. Talamini, F. Levi, P. Zambon, L. Dal Maso, C. Bosetti, S. Franceschi, and C. La Vecchia Family History of Cancer, Its Combination with Smoking and Drinking, and Risk of Squamous Cell Carcinoma of the Esophagus Cancer Epidemiol. Biomarkers Prev., June 1, 2005; 14(6): 1390 - 1393. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W-Q Wei, C C Abnet, N Lu, M J Roth, G-Q Wang, B A Dye, Z-W Dong, P R Taylor, P Albert, Y-L Qiao, et al. Risk factors for oesophageal squamous dysplasia in adult inhabitants of a high risk region of China Gut, June 1, 2005; 54(6): 759 - 763. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Savage, C. C. Abnet, S. D. Mark, Y.-L. Qiao, Z.-W. Dong, S. M. Dawsey, P. R. Taylor, and S. J. Chanock Variants of the IL8 and IL8RB Genes and Risk for Gastric Cardia Adenocarcinoma and Esophageal Squamous Cell Carcinoma Cancer Epidemiol. Biomarkers Prev., December 1, 2004; 13(12): 2251 - 2257. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Savage, C. C. Abnet, K. Haque, S. D. Mark, Y.-L. Qiao, Z.-W. Dong, S. M. Dawsey, P. R. Taylor, and S. J. Chanock Polymorphisms in Interleukin -2, -6, and -10 Are Not Associated with Gastric Cardia or Esophageal Cancer in a High-Risk Chinese Population Cancer Epidemiol. Biomarkers Prev., September 1, 2004; 13(9): 1547 - 1549. [Full Text] [PDF]
|
|
|
|
|
|
N. Hu, A. M. Goldstein, P. S. Albert, C. Giffen, Z.-Z. Tang, T. Ding, P. R. Taylor, and M. R. Emmert-Buck Evidence for a Familial Esophageal Cancer Susceptibility Gene on Chromosome 13 Cancer Epidemiol. Biomarkers Prev., October 1, 2003; 12(10): 1112 - 1115. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Su, N. Hu, J. Shih, Y. Hu, Q.-H. Wang, E. Y. Chuang, M. J. Roth, C. Wang, A. M. Goldstein, T. Ding, et al. Gene Expression Analysis of Esophageal Squamous Cell Carcinoma Reveals Consistent Molecular Profiles Related to a Family History of Upper Gastrointestinal Cancer Cancer Res., July 15, 2003; 63(14): 3872 - 3876. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Zhang, W. A. Schulz, Y. Li, R. Wang, R. Zotz, D. Wen, D. Siegel, D. Ross, H. E. Gabbert, and M. Sarbia Association of NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism with esophageal squamous cell carcinoma in a German Caucasian and a northern Chinese population Carcinogenesis, May 1, 2003; 24(5): 905 - 909. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Hu, G. Li, W.-J. Li, C. Wang, A. M. Goldstein, Z.-Z. Tang, M. J. Roth, S. M. Dawsey, J. Huang, Q.-H. Wang, et al. Infrequent Mutation in the BRCA2 Gene in Esophageal Squamous Cell Carcinoma Clin. Cancer Res., April 1, 2002; 8(4): 1121 - 1126. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Hu, J. Huang, M. R. Emmert-Buck, Z.-Z. Tang, M. J. Roth, C. Wang, S. M. Dawsey, G. Li, W.-J. Li, Q.-H. Wang, et al. Frequent Inactivation of the TP53 Gene in Esophageal Squamous Cell Carcinoma from a High-Risk Population in China Clin. Cancer Res., April 1, 2001; 7(4): 883 - 891. [Abstract] [Full Text]
|
|
|
|
|
|
J. Huang, N. Hu, A. M. Goldstein, M. R. Emmert-Buck, Z.-Z. Tang, M. J. Roth, Q.-H. Wang, S. M. Dawsey, X.-Y. Han, T. Ding, et al. High frequency allelic loss on chromosome 17p13.3-p11.1 in esophageal squamous cell carcinomas from a high incidence area in northern China Carcinogenesis, November 1, 2000; 21(11): 2019 - 2026. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Lagergren, W. Ye, A. Lindgren, and O. Nyrén Heredity and Risk of Cancer of the Esophagus and Gastric Cardia Cancer Epidemiol. Biomarkers Prev., July 1, 2000; 9(7): 757 - 760. [Abstract] [Full Text]
|
|
|
|
|
|
N. Hu, M. J. Roth, M. R. Emmert-Buck, Z.-Z. Tang, M. Polymeropolous, Q.-H. Wang, A. M. Goldstein, X.-Y. Han, S. M. Dawsey, T. Ding, et al. Allelic Loss in Esophageal Squamous Cell Carcinoma Patients with and without Family History of Upper Gastrointestinal Tract Cancer Clin. Cancer Res., November 1, 1999; 5(11): 3476 - 3482. [Abstract] [Full Text] [PDF]
|
|